Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Leukemia & Lymphoma|December 27, 2019
Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomasTaylor M Weis, Bernard L Marini, Victoria R Nachar, et al.European Journal of Haematology|November 6, 2023
Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of MichiganCharles E Foucar, Daniel H Foley, Jessica Aldous, et al.Leukemia & Lymphoma|June 14, 2022
Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginaseYeeAnn Chen, Kaitlyn Buhlinger, Anthony J Perissinotti, et al.Infection Control and Hospital Epidemiology|October 18, 2021
Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leukemiaAlina Varabyeva, Christabel Pui-See Lo, Adamo Brancaccio, et al.Leukemia Research|June 17, 2018
The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemiaVera Vulaj, Anthony J Perissinotti, James R Uebel, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 7, 2021
Utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML)Millicynth Talagtag, Twisha S Patel, Gianni B Scappaticci, et al.Current Oncology Reports|April 17, 2020
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant GliomaKyle Wierzbicki, Karthik Ravi, Andrea Franson, et al.Current Oncology Reports|February 8, 2020
Targeting and Therapeutic Monitoring of H3K27M-Mutant GliomaKyle Wierzbicki, Karthik Ravi, Andrea Franson, et al.Leukemia & Lymphoma|May 18, 2019
A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortageBernard L Marini, Julia Brown, Lydia Benitez, et al.Journal of Neuro-Oncology|December 14, 2017
Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncologyJoseph R Linzey, Bernard L Marini, Amy Pasternak, et al.Pageof 7